Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
JNCI Cancer Spectrum
|
February 22, 2023
p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer
Silvana Mouron, Maria J Bueno, Manuel Muñoz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 4, 2022
Corrigendum to "Quantum dots: The cutting-edge nanotheranostics in brain cancer management" [Journal of Controlled Release, Volume 350 (2022) Pages 698-715]
Pratik Chakraborty, Sabya Sachi Das, Abhijit Dey, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 3, 2022
Quantum dots: The cutting-edge nanotheranostics in brain cancer management
Pratik Chakraborty, Sabya Sachi Das, Abhijit Dey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2019
Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer
Miguel Quintela-Fandino, Serafín Morales, Alfonso Cortés-Salgado, et al.
Drug Delivery and Translational Research
|
November 16, 2021
Hydrogel composite containing azelaic acid and tea tree essential oil as a therapeutic strategy for Propionibacterium and testosterone-induced acne
Alpna Bisht, Chetna Hemrajani, Charul Rathore, et al.
Mayo Clinic Proceedings
|
February 4, 2018
Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding
Vivek N Iyer, Dinesh R Apala, Bibek S Pannu, et al.
Aging Cell
|
January 12, 2026
The Secretome of Human Trophoblast Stem Cells Attenuates Senescence-Associated Traits
Kotb Abdelmohsen, Jennifer L Martindale, Martina Rossi, et al.
Breast Cancer Research : BCR
|
November 12, 2020
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
Miguel Quintela-Fandino, Esther Holgado, Luis Manso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 2, 2026
Design of solubly expressed miniaturized SMART MHCs
William L White, Hua Bai, Chan Jhong Kim, et al.
Nature Communications
|
August 31, 2018
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
Ivana Zagorac, Sara Fernandez-Gaitero, Renske Penning, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
JNCI Cancer Spectrum
|
February 22, 2023
p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer
Silvana Mouron, Maria J Bueno, Manuel Muñoz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 4, 2022
Corrigendum to "Quantum dots: The cutting-edge nanotheranostics in brain cancer management" [Journal of Controlled Release, Volume 350 (2022) Pages 698-715]
Pratik Chakraborty, Sabya Sachi Das, Abhijit Dey, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 3, 2022
Quantum dots: The cutting-edge nanotheranostics in brain cancer management
Pratik Chakraborty, Sabya Sachi Das, Abhijit Dey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2019
Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer
Miguel Quintela-Fandino, Serafín Morales, Alfonso Cortés-Salgado, et al.
Drug Delivery and Translational Research
|
November 16, 2021
Hydrogel composite containing azelaic acid and tea tree essential oil as a therapeutic strategy for Propionibacterium and testosterone-induced acne
Alpna Bisht, Chetna Hemrajani, Charul Rathore, et al.
Mayo Clinic Proceedings
|
February 4, 2018
Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding
Vivek N Iyer, Dinesh R Apala, Bibek S Pannu, et al.
Aging Cell
|
January 12, 2026
The Secretome of Human Trophoblast Stem Cells Attenuates Senescence-Associated Traits
Kotb Abdelmohsen, Jennifer L Martindale, Martina Rossi, et al.
Breast Cancer Research : BCR
|
November 12, 2020
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
Miguel Quintela-Fandino, Esther Holgado, Luis Manso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 2, 2026
Design of solubly expressed miniaturized SMART MHCs
William L White, Hua Bai, Chan Jhong Kim, et al.
Nature Communications
|
August 31, 2018
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
Ivana Zagorac, Sara Fernandez-Gaitero, Renske Penning, et al.
Page
of 13